- Home
- MREO vs MYN Comparison
MREO vs MYN Comparison
Compare MREO & MYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- MYN
- Stock Information
- Founded
- MREO 2015
- MYN 1992
- Country
- MREO United Kingdom
- MYN United States
- Employees
- MREO N/A
- MYN N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- MYN Finance Companies
- Sector
- MREO Health Care
- MYN Finance
- Exchange
- MREO Nasdaq
- MYN Nasdaq
- Market Cap
- MREO 369.2M
- MYN 379.9M
- IPO Year
- MREO N/A
- MYN N/A
- Fundamental
- Price
- MREO $2.26
- MYN $9.94
- Analyst Decision
- MREO Strong Buy
- MYN
- Analyst Count
- MREO 7
- MYN 0
- Target Price
- MREO $7.71
- MYN N/A
- AVG Volume (30 Days)
- MREO 1.2M
- MYN 86.0K
- Earning Date
- MREO 03-26-2025
- MYN 01-01-0001
- Dividend Yield
- MREO N/A
- MYN 4.12%
- EPS Growth
- MREO N/A
- MYN N/A
- EPS
- MREO N/A
- MYN N/A
- Revenue
- MREO N/A
- MYN N/A
- Revenue This Year
- MREO N/A
- MYN N/A
- Revenue Next Year
- MREO $69.09
- MYN N/A
- P/E Ratio
- MREO N/A
- MYN N/A
- Revenue Growth
- MREO N/A
- MYN N/A
- 52 Week Low
- MREO $2.16
- MYN $8.47
- 52 Week High
- MREO $5.02
- MYN $10.62
- Technical
- Relative Strength Index (RSI)
- MREO 33.19
- MYN 42.15
- Support Level
- MREO $2.23
- MYN $9.80
- Resistance Level
- MREO $2.73
- MYN $10.17
- Average True Range (ATR)
- MREO 0.14
- MYN 0.10
- MACD
- MREO -0.01
- MYN -0.01
- Stochastic Oscillator
- MREO 7.89
- MYN 37.84
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About MYN Blackrock MuniYield New York Quality Fund Inc.Common Stock
Blackrock Muniyield NY Quality FD, Inc is a closed-end management investment company. Its objective is to provide shareholders with a high level of current income exempt from federal income taxes. The Fund invests in long-term municipal obligations that are investment grade quality or are considered by the Fund's investment adviser to be of comparable quality, at the time of investment.